Home/Filings/4/0001317757-11-000002
4//SEC Filing

Zieziula Gary J 4

Accession 0001317757-11-000002

CIK 0000792977other

Filed

Jan 10, 7:00 PM ET

Accepted

Jan 11, 9:12 PM ET

Size

8.7 KB

Accession

0001317757-11-000002

Insider Transaction Report

Form 4
Period: 2011-01-07
Zieziula Gary J
EVP, Chief Commercial Officer
Transactions
  • Award

    Restricted stock unit

    2011-01-07+25,00025,000 total
    Common stock (25,000 underlying)
  • Award

    Restricted stock unit

    2011-01-07+5,0005,000 total
    Common stock (5,000 underlying)
Footnotes (5)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F2]Grant of restricted stock unit pursuant to the AMAG Pharmaceuticals, Inc. Second Amended and Restated 2007 Equity Incentive Plan. The grant will vest in three installments. The first installment of 12,500 restricted stock units will vest on January 7, 2012. The remaining two installments of 6,250 restricted stock units each will vest on January 7, 2013 and January 7, 2014, respectively.
  • [F3]Not applicable.
  • [F4]Price is not applicable.
  • [F5]Grant of restricted stock unit pursuant to the AMAG Pharmaceuticals, Inc. Second Amended and Restated 2007 Equity Incentive Plan. The grant will vest in its entirety in a single installment on the earlier to occur of: January 7, 2015, or immediately prior to a change of control of the Company, provided that in either case the closing price of the Company's stock is at least $30 per share.

Issuer

AMAG PHARMACEUTICALS INC.

CIK 0000792977

Entity typeother

Related Parties

1
  • filerCIK 0001489616

Filing Metadata

Form type
4
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 9:12 PM ET
Size
8.7 KB